PETIQ INC (PETQ) Stock Price, Forecast & Analysis
USA - NASDAQ:PETQ - US71639T1060 - Common Stock
PETQ Key Statistics, Chart & Performance
The current stock price of PETQ is 30.98 USD. In the past month the price increased by 0.78%. In the past year, price increased by 69.1%.
PETQ Latest News, Press Relases and Analysis
PETQ Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.61 | 106.52B | ||
| COR | CENCORA INC | 22.83 | 70.78B | ||
| CAH | CARDINAL HEALTH INC | 22.99 | 48.66B | ||
| HSIC | HENRY SCHEIN INC | 15.19 | 8.88B | ||
| AHCO | ADAPTHEALTH CORP | 29.81 | 1.29B | ||
| OMI | OWENS & MINOR INC | 2.21 | 220.13M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 54.01M |
Related stock screener links
About PETQ
Company Profile
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,933 full-time employees. The company went IPO on 2017-07-21. The firm operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. The company is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Company Info
PETIQ INC
Petiq Llc, 230 E. Riverside Dr.
Eagle IDAHO 83616 US
CEO: McCord Christensen
Employees: 1933
Phone: 12089398900
PETIQ INC / PETQ FAQ
What does PETQ do?
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,933 full-time employees. The company went IPO on 2017-07-21. The firm operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. The company is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
What is the current price of PETQ stock?
The current stock price of PETQ is 30.98 USD. The price decreased by -0.03% in the last trading session.
Does PETIQ INC pay dividends?
PETQ does not pay a dividend.
How is the ChartMill rating for PETIQ INC?
PETQ has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Would investing in PETIQ INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PETQ.
What is the market capitalization of PETQ stock?
PETIQ INC (PETQ) has a market capitalization of 933.43M USD. This makes PETQ a Small Cap stock.
PETQ Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PETQ. When comparing the yearly performance of all stocks, PETQ is one of the better performing stocks in the market, outperforming 93.86% of all stocks.
PETQ Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PETQ. Both the profitability and the financial health of PETQ get a neutral evaluation. Nothing too spectacular is happening here.
PETQ Financial Highlights
Over the last trailing twelve months PETQ reported a non-GAAP Earnings per Share(EPS) of 1.58. The EPS increased by 64.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.17% | ||
| ROA | 1.48% | ||
| ROE | 5.13% | ||
| Debt/Equity | 1.69 |
PETQ Forecast & Estimates
11 analysts have analysed PETQ and the average price target is 31.11 USD. This implies a price increase of 0.42% is expected in the next year compared to the current price of 30.98.
For the next year, analysts expect an EPS growth of 34.03% and a revenue growth 8.33% for PETQ